2016 Q3 Form 10-K Financial Statement

#000114420416128038 Filed on October 13, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q2 2015 Q2
Revenue $0.00 $0.00 $40.00K
YoY Change -100.0% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $480.0K $290.0K $120.0K
YoY Change -18.64% 141.67% -73.33%
% of Gross Profit
Research & Development $280.2K $410.0K $840.0K
YoY Change -53.42% -51.19% -22.94%
% of Gross Profit
Depreciation & Amortization $10.00K $10.00K $40.00K
YoY Change -66.67% -75.0% -63.64%
% of Gross Profit
Operating Expenses $280.2K $1.400M $960.0K
YoY Change -53.42% 45.83% -41.46%
Operating Profit -$2.211M
YoY Change 91.99%
Interest Expense -$74.00 $30.00K $0.00
YoY Change -73.76%
% of Operating Profit
Other Income/Expense, Net $430.0K -$60.00K $10.00K
YoY Change 2050.0% -700.0%
Pretax Income -$1.574M -$1.430M -$910.0K
YoY Change 770.62% 57.14% -75.2%
Income Tax -$640.0K -$280.0K
% Of Pretax Income
Net Earnings -$933.6K -$1.150M -$910.0K
YoY Change 416.52% 26.37% -75.2%
Net Earnings / Revenue -2275.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$911.8K -$1.127M -$1.138M
COMMON SHARES
Basic Shares Outstanding 20.50M shares 16.39M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q3 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $290.0K $810.0K $3.330M
YoY Change -91.34% -75.68% -45.5%
Cash & Equivalents $287.1K $810.8K $3.335M
Short-Term Investments
Other Short-Term Assets $90.00K $170.0K $400.0K
YoY Change -70.0% -57.5% -62.62%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $380.0K $982.6K $3.730M
YoY Change -89.59% -73.65% -48.37%
LONG-TERM ASSETS
Property, Plant & Equipment $80.00K $92.55K $185.9K
YoY Change -46.67% -50.23% -16.79%
Goodwill $0.00 $5.781M
YoY Change -100.0% -58.42%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $60.00K $50.00K $50.00K
YoY Change 20.0% 0.0% 400.0%
Total Long-Term Assets $6.630M $8.243M $15.82M
YoY Change -58.01% -47.89% -39.42%
TOTAL ASSETS
Total Short-Term Assets $380.0K $982.6K $3.730M
Total Long-Term Assets $6.630M $8.243M $15.82M
Total Assets $7.010M $9.226M $19.55M
YoY Change -63.94% -52.8% -41.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $140.0K $90.31K $232.0K
YoY Change -17.65% -61.08% -74.25%
Accrued Expenses $320.0K $256.4K $408.7K
YoY Change -20.0% -37.27% -55.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $470.0K $369.0K $778.5K
YoY Change -30.88% -52.6% -57.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $320.0K $99.73K $122.0K
YoY Change -86.32% -18.28% 22.37%
Total Long-Term Liabilities $320.0K $99.73K $122.0K
YoY Change -86.32% -18.28% 22.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $470.0K $369.0K $778.5K
Total Long-Term Liabilities $320.0K $99.73K $122.0K
Total Liabilities $3.390M $4.665M $7.323M
YoY Change -51.08% -36.29% 25.28%
SHAREHOLDERS EQUITY
Retained Earnings -$115.6M -$107.2M
YoY Change 7.88%
Common Stock $205.0K $187.5K
YoY Change 9.3% 35.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.630M $4.561M $12.22M
YoY Change
Total Liabilities & Shareholders Equity $7.010M $9.226M $19.55M
YoY Change -63.94% -52.8% -41.36%

Cashflow Statement

Concept 2016 Q3 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$933.6K -$1.150M -$910.0K
YoY Change 416.52% 26.37% -75.2%
Depreciation, Depletion And Amortization $10.00K $10.00K $40.00K
YoY Change -66.67% -75.0% -63.64%
Cash From Operating Activities -$573.7K -$720.0K -$2.420M
YoY Change -49.23% -70.25% 98.36%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $460.0K
YoY Change -100.0% -309.09%
Acquisitions
YoY Change
Other Investing Activities $50.00K $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $50.00K $0.00 $460.0K
YoY Change -100.0% -56.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000 4.830M
YoY Change -100.0% -100.0% 6800.0%
NET CHANGE
Cash From Operating Activities -$573.7K -720.0K -2.420M
Cash From Investing Activities $50.00K 0.000 460.0K
Cash From Financing Activities $0.00 0.000 4.830M
Net Change In Cash -$523.7K -720.0K 2.870M
YoY Change -2718.72% -125.09% -3288.89%
FREE CASH FLOW
Cash From Operating Activities -$573.7K -$720.0K -$2.420M
Capital Expenditures $0.00 $460.0K
Free Cash Flow -$720.0K -$2.880M
YoY Change -75.0% 188.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 svon Finitelived Intangible Assets Written Off
FinitelivedIntangibleAssetsWrittenOff
-2290836 USD
CY2016 us-gaap Licenses Revenue
LicensesRevenue
75000 USD
CY2015 us-gaap Licenses Revenue
LicensesRevenue
75000 USD
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
11269983 USD
CY2015 us-gaap Costs And Expenses
CostsAndExpenses
18151736 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-11194983 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-18076736 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-8267929 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-18063785 USD
CY2016 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
179154 USD
CY2015 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
838925 USD
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8447083 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18902710 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8447083 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18902710 USD
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.31
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20322714 shares
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14417029 shares
CY2014 us-gaap Licenses Revenue
LicensesRevenue
100000 USD
CY2014 us-gaap Costs And Expenses
CostsAndExpenses
9247796 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-9147796 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-9225234 USD
CY2014 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4629197 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13854431 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13854431 USD
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.53
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5476717 shares
CY2016 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1993560 USD
CY2015 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
3313 USD
CY2014 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 USD
CY2016 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-533 USD
CY2015 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2767 USD
CY2014 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-77438 USD
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1606043 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3170499 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3683350 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2182989 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4568435 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3338687 USD
CY2016 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2015 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2014 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
544978 USD
CY2016 svon Finitelived Intangible Assets Written Off
FinitelivedIntangibleAssetsWrittenOff
0 USD
CY2015 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4827569 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1152397 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2523818 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6111340 USD
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
5780951 USD
CY2015 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
8121966 USD
CY2014 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119983399 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119217880 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115630059 USD
CY2014 svon Finitelived Intangible Assets Written Off
FinitelivedIntangibleAssetsWrittenOff
-1680781 USD
CY2016 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
254027 USD
CY2015 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
12405 USD
CY2014 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
810808 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3334626 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
982628 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
3729726 USD
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92554 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
185948 USD
CY2016Q2 svon Acquired Research And Development
AcquiredResearchAndDevelopment
8100000 USD
CY2015Q2 svon Acquired Research And Development
AcquiredResearchAndDevelopment
9800000 USD
CY2016Q2 us-gaap Goodwill
Goodwill
0 USD
CY2015Q2 us-gaap Goodwill
Goodwill
5780951 USD
CY2016Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
50770 USD
CY2015Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
50770 USD
CY2016Q2 us-gaap Assets
Assets
9225952 USD
CY2015Q2 us-gaap Assets
Assets
19547395 USD
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
90305 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
232033 USD
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
256376 USD
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
408705 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
368991 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
778516 USD
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3240000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3920000 USD
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
99728 USD
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
122038 USD
CY2016Q2 us-gaap Liabilities
Liabilities
4665294 USD
CY2015Q2 us-gaap Liabilities
Liabilities
7322601 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
204964 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
187528 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-107182976 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
4560658 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
12224794 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9225952 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19547395 USD
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
171820 USD
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
395100 USD
CY2016Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
956575 USD
CY2015Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2502047 USD
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22310 USD
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
137778 USD
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Entity Registrant Name
EntityRegistrantName
Sevion Therapeutics, Inc.
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001035354
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2016 svon Maturity Of Cash And Cash Equivalents
MaturityOfCashAndCashEquivalents
P90D
CY2016 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1152397 USD
CY2016 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2015 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4827569 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2776714 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1297224 USD
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
349656 USD
CY2014 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2014 svon Writeoff Of Prepaid Research Supplies
WriteoffOfPrepaidResearchSupplies
0 USD
CY2014 svon Deferred Rent
DeferredRent
0 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-868837 USD
CY2014 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
0 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-145257 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
305860 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4868133 USD
CY2014 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
624532 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3194 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
646936 USD
CY2014 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2187082 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1602294 USD
CY2016 svon Gain Loss On Settlement Of Warrant Liabilities
GainLossOnSettlementOfWarrantLiabilities
0 USD
CY2015 svon Gain Loss On Settlement Of Warrant Liabilities
GainLossOnSettlementOfWarrantLiabilities
0 USD
CY2014 svon Gain Loss On Settlement Of Warrant Liabilities
GainLossOnSettlementOfWarrantLiabilities
0 USD
CY2016 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2015 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2014 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
1274662 USD
CY2015 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2290836 USD
CY2014 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1680781 USD
CY2016 svon Unrealized Gain Loss On Stock Rights
UnrealizedGainLossOnStockRights
254027 USD
CY2015 svon Unrealized Gain Loss On Stock Rights
UnrealizedGainLossOnStockRights
12405 USD
CY2014 svon Unrealized Gain Loss On Stock Rights
UnrealizedGainLossOnStockRights
0 USD
CY2016 svon Unrealized Gain Loss On Warrant Derivatives
UnrealizedGainLossOnWarrantDerivatives
1993560 USD
CY2015 svon Unrealized Gain Loss On Warrant Derivatives
UnrealizedGainLossOnWarrantDerivatives
3313 USD
CY2014 svon Unrealized Gain Loss On Warrant Derivatives
UnrealizedGainLossOnWarrantDerivatives
0 USD
CY2016 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-8071 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-75000 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
75000 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2016Q2 svon Development Stage Enterprise Deficit Accumulated During Development Stages
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStages
115630059 USD
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
3920000 USD
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
20709047 USD
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
19542 USD
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment
234000 USD
CY2014Q2 svon Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Acquired Research And Development
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquiredResearchAndDevelopment
9800000 USD
CY2014Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
13902917 USD
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
409117 USD
CY2014Q2 svon Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable Accrued Payroll
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedPayroll
74525 USD
CY2014Q2 svon Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable Accrued Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpenses
161565 USD
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13472524 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11824731 shares
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
156678 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
480681 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1297224 USD
CY2014Q2 svon Business Combination Purchase Price Options To Be Recognized In Future
BusinessCombinationPurchasePriceOptionsToBeRecognizedInFuture
-224812 USD
CY2014Q2 svon Business Combination Purchase Price Allocation For Goodwill Calculation
BusinessCombinationPurchasePriceAllocationForGoodwillCalculation
20709047 USD
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
1274662 USD
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
43133 USD
CY2014 us-gaap Revenues
Revenues
182229 USD
CY2014 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-11017792 USD
CY2014 us-gaap Profit Loss
ProfitLoss
-5646989 USD
CY2014 svon Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-1.36
CY2014Q2 us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
6905201 shares
CY2014Q2 us-gaap Business Acquisition Equity Interest Issued Or Issuable Value Assigned
BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
18298782 USD
CY2014Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3578481 shares
CY2014Q2 svon Warrant To Purchase Of Common Stock Fair Value Amount
WarrantToPurchaseOfCommonStockFairValueAmount
2349853 USD
CY2014Q2 invest Investment Options Exercise Price
InvestmentOptionsExercisePrice
2.65
CY2014Q2 svon Options To Purchase Of Common Stock Fair Value Amount
OptionsToPurchaseOfCommonStockFairValueAmount
285224 USD
CY2014Q2 svon Business Combination Purchase Price For Valuation
BusinessCombinationPurchasePriceForValuation
20933859 USD
CY2014Q2 svon Business Acquisition Additional Purchase Price Prior To Acquisition Services
BusinessAcquisitionAdditionalPurchasePricePriorToAcquisitionServices
60412 USD
CY2014Q2 svon Business Acquisition Amortized Expenses Post To Acquisition Services
BusinessAcquisitionAmortizedExpensesPostToAcquisitionServices
224812 USD
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q4 dei Entity Public Float
EntityPublicFloat
6807255 USD
CY2016 dei Trading Symbol
TradingSymbol
SVON
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20496385 shares
CY2016 svon Common Stock Proceeds To Warrants
CommonStockProceedsToWarrants
559261 USD
CY2016 svon Common Stock Proceeds To Stock Rights
CommonStockProceedsToStockRights
142854 USD
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
256805 USD
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
163412 USD
CY2016 us-gaap Depreciation
Depreciation
93394 USD
CY2015 us-gaap Depreciation
Depreciation
152097 USD
CY2014 us-gaap Depreciation
Depreciation
18275 USD
CY2014Q4 svon Acquired Research And Development
AcquiredResearchAndDevelopment
9800000 USD
CY2014Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
283393 USD
CY2014Q4 us-gaap Goodwill
Goodwill
13902917 USD
CY2014Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
8121966 USD
CY2014Q3 svon Writeoff Of Prepaid Research Supplies
WriteoffOfPrepaidResearchSupplies
669750 USD
CY2014 svon Impairment Of Patents
ImpairmentOfPatents
330190 USD
CY2016 us-gaap Legal Fees
LegalFees
421287 USD
CY2015 us-gaap Legal Fees
LegalFees
219270 USD
CY2016Q2 svon Accrued Research And Development Expen
AccruedResearchAndDevelopmentExpen
66409 USD
CY2015Q2 svon Accrued Research And Development Expen
AccruedResearchAndDevelopmentExpen
48909 USD
CY2014 svon Probability To Achieve Employee Target Goals
ProbabilityToAchieveEmployeeTargetGoals
0.81 pure
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
392860 shares
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
47345 USD
CY2015 svon Probability To Achieve Employee Target Goals
ProbabilityToAchieveEmployeeTargetGoals
0.81 pure
CY2014Q4 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
237291 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
85504 shares
CY2014Q4 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
51645 USD
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
70350 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
778480 shares
CY2016Q2 svon Accrued Dividends Current
AccruedDividendsCurrent
9502 USD
CY2015Q2 svon Accrued Dividends Current
AccruedDividendsCurrent
6335 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1203676 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
485682 shares
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2014 svon Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
27788 shares
CY2015 svon Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
552471 shares
CY2016Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
74240 USD
CY2015Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
135497 USD
CY2016Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
106225 USD
CY2015Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
217964 USD
CY2016Q2 svon Preferred Stock Stated Value Per Share
PreferredStockStatedValuePerShare
1000
CY2016 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.1 pure
CY2015 svon Stock Issued During Period Shares Stock Dividend
StockIssuedDuringPeriodSharesStockDividend
59500 shares
CY2014 svon Stock Issued During Period Shares Stock Dividend
StockIssuedDuringPeriodSharesStockDividend
17524 shares
CY2016 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
40286 USD
CY2015 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
56583 USD
CY2016 svon Stock Issued During Period Shares Stock Dividend
StockIssuedDuringPeriodSharesStockDividend
108576 shares
CY2016Q2 svon Stock Conversion Price Per Share
StockConversionPricePerShare
0.75
CY2016Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.01
CY2015 svon Common Stock Proceeds To Stock Rights
CommonStockProceedsToStockRights
775062 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
37050 shares
CY2012Q4 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
489060 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
46780 shares
CY2013Q3 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
201154 USD
CY2016 svon Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
151588 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3136 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3590 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
43775 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1841728 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
428286 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1228739 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.94
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.73
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.31
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
16.5
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.41
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.99
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
229.65
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
289.09
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
11.02
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.38
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.48
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><i><font style="FONT-SIZE: 10pt">Concentrations of Credit Risk</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash. The Company maintains cash balances at financial institutions, which at times, exceed federally insured limits. At June 30, 2016 and 2015, the Company&#8217;s cash amount on deposit was in excess of FDIC insurance limits. The Company has not recognized any losses from credit risks on such accounts since inception. The Company believes it is not exposed to significant credit risk on cash.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.53
CY2014 svon Share Based Compensation Shares Authorized Under Stock Option Plans Exercised In Period Exercise Price
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisedInPeriodExercisePrice
0
CY2015 svon Share Based Compensation Shares Authorized Under Stock Option Plans Exercised In Period Exercise Price
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisedInPeriodExercisePrice
0
CY2014 svon Share Based Compensation Shares Authorized Under Stock Option Plans Cancelled In Period Exercise Price
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansCancelledInPeriodExercisePrice
16.5
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
485682 shares
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
656639 shares
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
151713 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.31
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.4
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.01
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M2D
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y6M7D
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4020462 shares
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
51183 USD
CY2016Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.5 pure
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4261000 USD
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.22 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.153 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.084 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.004 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.031 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.007 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.03 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.288 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.245 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.363 pure
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.076 pure
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2016Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26096000 USD
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23719000 USD
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1386000 USD
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2721000 USD
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
1281000 USD
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
651000 USD
CY2016Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
28763000 USD
CY2014Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
27091000 USD
CY2016Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
3240000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
3920000 USD
CY2016Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3240000 USD
CY2014Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3920000 USD
CY2016Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
28763000 USD
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
27091000 USD
CY2016Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3240000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3920000 USD
CY2016Q2 us-gaap Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
94342 USD
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
861236 USD
CY2014 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
20001 USD
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><i><font style="FONT-SIZE: 10pt">Management Estimates and Judgments</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><font style="FONT-SIZE: 10pt">Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. This process may result in actual results differing materially from those estimated amounts used in the preparation of the financial statements if these results differ from historical experience, or other assumptions do not turn out to be substantially accurate, even if such assumptions are reasonable when made. In preparing these financial statements, management used significant estimates in the following areas, among others: stock-based compensation expense, warrant and stock rights liabilities, the determination of the fair value of equity transactions and stock-based awards, the accounting for research and development costs, the accounting for goodwill and impairment and accrued expenses.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20496385 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20496385 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18752813 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18752813 shares
CY2016 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
1700000 USD
CY2015 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2014 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8947929 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18063785 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9225234 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-680000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
3786067 USD
CY2014 svon Issuance Of Common Stock And Warrants Value
IssuanceOfCommonStockAndWarrantsValue
6839006 USD
CY2014 svon Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
4078621 USD
CY2014 svon Cash Paid For Fractional Shares Due To Reverse Split
CashPaidForFractionalSharesDueToReverseSplit
303 USD
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
435988 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
0 USD
CY2014 us-gaap Dividends
Dividends
14500 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
27489929 USD
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4827569 USD
CY2015 svon Allocation Of Common Stock Proceeds To Warrant Liability
AllocationOfCommonStockProceedsToWarrantLiability
1742703 USD
CY2015 svon Allocation Of Common Stock Proceeds To Derivative Stock Right
AllocationOfCommonStockProceedsToDerivativeStockRight
775062 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
480681 USD
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2015 svon Deemed Dividends On Preferred Stock
DeemedDividendsOnPreferredStock
0 USD
CY2015 us-gaap Dividends Common Stock
DividendsCommonStock
14500 USD
CY2015 us-gaap Dividends Preferred Stock
DividendsPreferredStock
6335 USD
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1152397 USD
CY2016 svon Allocation Of Common Stock Proceeds To Warrant Liability
AllocationOfCommonStockProceedsToWarrantLiability
559261 USD
CY2016 svon Allocation Of Common Stock Proceeds To Derivative Stock Right
AllocationOfCommonStockProceedsToDerivativeStockRight
142854 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
156678 USD
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2016 svon Deemed Dividends On Preferred Stock
DeemedDividendsOnPreferredStock
0 USD
CY2016 us-gaap Dividends Common Stock
DividendsCommonStock
6335 USD
CY2016 us-gaap Dividends Preferred Stock
DividendsPreferredStock
9502 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
6750 USD
CY2015 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
998 USD
CY2014 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
731 USD
CY2015 svon Common Stock Proceeds To Warrants
CommonStockProceedsToWarrants
1742703 USD
CY2014 svon Common Stock Proceeds To Warrants
CommonStockProceedsToWarrants
0 USD
CY2014 svon Common Stock Proceeds To Stock Rights
CommonStockProceedsToStockRights
0 USD
CY2016 svon Common Stock Proceeds To Warrants And Conversion
CommonStockProceedsToWarrantsAndConversion
135701 USD
CY2015 svon Common Stock Proceeds To Warrants And Conversion
CommonStockProceedsToWarrantsAndConversion
790507 USD
CY2014 svon Common Stock Proceeds To Warrants And Conversion
CommonStockProceedsToWarrantsAndConversion
0 USD
CY2016 us-gaap Stock Issued1
StockIssued1
40286 USD
CY2015 us-gaap Stock Issued1
StockIssued1
56583 USD
CY2014 us-gaap Stock Issued1
StockIssued1
118617 USD
CY2016 svon Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
9502 USD
CY2015 svon Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
6335 USD
CY2014 svon Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
14500 USD
CY2016 us-gaap Interest Paid
InterestPaid
0 USD
CY2015 us-gaap Interest Paid
InterestPaid
137 USD
CY2014 us-gaap Interest Paid
InterestPaid
85893 USD
CY2014 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
20709047 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Accounts Receivable Acquired1
NoncashOrPartNoncashAcquisitionAccountsReceivableAcquired1
43133 USD
CY2014 svon Non Cash Or Part Non Cash Acquisition Prepaid Expenses
NonCashOrPartNonCashAcquisitionPrepaidExpenses
19542 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
234000 USD
CY2014 svon Non Cash Or Part Non Cash Acquisition Acquired Research And Development
NonCashOrPartNonCashAcquisitionAcquiredResearchAndDevelopment
9800000 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
13902917 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
23999592 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
409117 USD
CY2014 svon Non Cash Or Part Non Cash Acquisition Accrued Pay Roll
NonCashOrPartNonCashAcquisitionAccruedPayRoll
74525 USD
CY2014 svon Non Cash Or Part Non Cash Acquisition Accrued Expenses
NonCashOrPartNonCashAcquisitionAccruedExpenses
161565 USD
CY2014 svon Non Cash Or Part Non Cash Acquisition Deferred Tax Liability
NonCashOrPartNonCashAcquisitionDeferredTaxLiability
3920000 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
4565207 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
1274662 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0215 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0232 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.027 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.69 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.95 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.85 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.46 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.99 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.53 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.00 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0002 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.016 pure
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
25274254 USD
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
4565207 USD
CY2015 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P2Y4M24D
CY2015 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0073 pure
CY2014Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0 USD
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
349359 USD
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
349360 USD
CY2016 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0064 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.287 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.171 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2015Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27224000 USD
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2843000 USD
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
1285000 USD
CY2015Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31352000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
3920000 USD
CY2015Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3920000 USD
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31352000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3920000 USD
CY2015 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
1.1520 pure
CY2016 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
1.1090 pure
CY2015 us-gaap Fair Value Assumptions Expected Dividend Payments
FairValueAssumptionsExpectedDividendPayments
0
CY2016 us-gaap Fair Value Assumptions Expected Dividend Payments
FairValueAssumptionsExpectedDividendPayments
0
CY2016 svon Share Reserve Increase
ShareReserveIncrease
0.05 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.25 pure
CY2016 us-gaap Preferred Stock Dividend Payment Terms
PreferredStockDividendPaymentTerms
If the dividends are paid in shares of Common Stock, such shares will be priced at the lower of 90% of the average volume weighted-average price for the 20 trading days immediately preceding the payment date or $22.40.
CY2016 us-gaap Other Commitments Description
OtherCommitmentsDescription
The agreement included a penalty of 1% per month of the investor&#8217;s investment, payable in cash, for every 30 day period up to a maximum of 6% for failure to comply with the terms of the agreement. In the event the listing is not continuously maintained for five years after the closing date, on each monthly anniversary of each such listing default date until the applicable listing default is cured, the Company would pay to each subscriber an amount in cash, as partial liquidated damages equal to 1% of the subscriber&#8217;s amounts invested held as of each such date
CY2016 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1700000 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-680000 USD
CY2016 svon Probability To Achieve Employee Target Goals
ProbabilityToAchieveEmployeeTargetGoals
0.81 pure
CY2014 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
20709047 USD
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P36M
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
398180 shares
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
75510 shares
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.81
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.76
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
231748 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
979304 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1626919 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1917238 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
50.00
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.49
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.45
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.29
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2590000 USD
CY2015Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2800000 USD
CY2016Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1000000 USD
CY2016Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2981000 USD
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.035 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.032 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.054 pure
CY2016Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
8800000 USD

Files In Submission

Name View Source Status
0001144204-16-128038-index-headers.html Edgar Link pending
0001144204-16-128038-index.html Edgar Link pending
0001144204-16-128038.txt Edgar Link pending
0001144204-16-128038-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
svon-20160630.xml Edgar Link completed
svon-20160630.xsd Edgar Link pending
svon-20160630_cal.xml Edgar Link unprocessable
svon-20160630_def.xml Edgar Link unprocessable
svon-20160630_lab.xml Edgar Link unprocessable
svon-20160630_pre.xml Edgar Link unprocessable
v450276_10k.htm Edgar Link pending
v450276_ex23-1.htm Edgar Link pending
v450276_ex31-1.htm Edgar Link pending
v450276_ex31-2.htm Edgar Link pending
v450276_ex32-1.htm Edgar Link pending
v450276_ex32-2.htm Edgar Link pending